ABBV vs ELV
By Alex · Tickerpine
AbbVie Inc. vs Elevance Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | ELV |
|---|---|---|
| Price | $295.03 | $429.69 |
| Market cap | $521.50B | $92.84B |
| P/E ratio | 50.7 | 18.2 |
| ROE | — | 11.48% |
| Profit margin | 15.67% | 2.55% |
| Revenue growth | 10.30% | 1.40% |
| Dividend yield | 2.35% | 1.60% |
| Beta | 0.19 | 0.63 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs ELV in plain English
- ABBV is the bigger company — about 5.6× the market cap of ELV.
- ELV is cheaper on earnings (P/E 18.2 vs 50.7).
- ABBV is growing revenue faster (10% vs 1%).
- ABBV has the higher dividend yield (2.35% vs 1.60%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
ELV return calculator
See what $1,000 in Elevance Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.